换一批Impact of immunochemotherapy regimens on outcomes of patients with primary mediastinal B-cell lymphoma in the IELSG37 trial.
第一作者：
Emanuele,Zucca
第一单位：
Clinic of Hematology, Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.;Institute of Oncology Research, Bellinzona, Switzerland.;Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland.
作者：
Emanuele,Zucca [1]
;
Luca,Ceriani [2]
;
Giovannino,Ciccone [3]
;
Alice,Di Rocco [4]
;
Maria Cristina,Pirosa [5]
;
Iryna,Kriachok [6]
;
Barbara,Botto [7]
;
Monica,Balzarotti [8]
;
Alessandra,Tucci [9]
;
Sara Veronica,Usai [10]
;
Vittorio Ruggero,Zilioli [11]
;
Elsa,Pennese [12]
;
Luca,Arcaini [13]
;
Anna,Dabrowska-Iwanicka [14]
;
Andrés J M,Ferreri [15]
;
Francesco,Merli [16]
;
Weili,Zhao [17]
;
Luigi,Rigacci [18]
;
Claudia,Cellini [19]
;
David,Hodgson [20]
;
Codruta,Ionescu [21]
;
Carla,Minoia [22]
;
Elisa,Lucchini [23]
;
Michele,Spina [24]
;
Alexander,Fosså [25]
;
Andrea,Janikova [26]
;
Kate,Cwynarski [27]
;
N George,Mikhaeel [28]
;
Mats,Jerkeman [29]
;
Anastasios,Stathis [30]
;
Kelly,Cozens [31]
;
Nicoletta,Ielmini [32]
;
Iolanda,De Martino [33]
;
Jan,Walewski [14]
;
Marek,Trneny [34]
;
Franco,Cavalli [32]
;
Umberto,Ricardi [35]
;
Peter W M,Johnson [36]
;
Andrew,Davies [36]
;
Maurizio,Martelli [4]
作者单位：
Clinic of Hematology, Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.;Institute of Oncology Research, Bellinzona, Switzerland.;Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland.
[1]
Institute of Oncology Research, Bellinzona, Switzerland.;Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland.;Nuclear Medicine and PET-CT Centre, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland.
[2]
Clinical Epidemiology Unit, Oncology Department, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino and Centro di Riferimento Regionale per l'Epidemiologia e la Prevenzione Oncologia Piemonte Piemonte, Turin, Italy.
[3]
Division of Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
[4]
Clinic of Hematology, Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.;Institute of Oncology Research, Bellinzona, Switzerland.
[5]
Onco-Hematology Department, National Cancer Institute, Kyiv, Ukraine.
[6]
Department of Hematology, Azienda Ospedaliero Universitaria Città della Salute e della Scienza, Turin, Italy.
[7]
Department of Medical Oncology and Hematology, IRCCS Humanitas Research Hospital, Milan, Italy.
[8]
Department of Haematology, Azienda Socio Sanitaria Territoriale Spedali Civili, Brescia, Italy.
[9]
Unità Operativa Ematologia e Centro Trapianto di Midollo Osseo, Ospedale Oncologico Businco, Azienda Ospedaliera Brotzu, Cagliari, Italy.
[10]
Division of Hematology, Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Milan, Italy.
[11]
Unità Operativa Semplice Dipartimentale Centro Diagnosi e Terapia Linfomi, Presidio Ospedaliero Pescara, Pescara, Italy.
[12]
Department of Molecular Medicine, University of Pavia, Pavia, Italy.;Division of Hematology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy.
[13]
Department of Lymphoid Malignancies, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
[14]
Lymphoma Unit, Department of Onco-Hematology, Istituto di Ricovero e Cura a Carattere Scientifico Ospedale San Raffaele, Milan, Italy.;Vita-Salute San Raffaele University, Milan, Italy.
[15]
Department of Hematology, Azienda Unità Sanitaria Locale-Istituto di Ricovero e Cura a Carattere Scientifico di Reggio Emilia, Reggio Emilia, Italy.
[16]
Department of Hematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
[17]
Department of Hematology, Azienda Ospedaliera Universitaria Careggi, Florence, Italy.
[18]
Department of Hematology, Ospedale Santa Maria delle Croci, Ravenna, Italy.
[19]
Radiation Therapy Centre, Princess Margaret Cancer Centre, Toronto, Canada.
[20]
Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
[21]
Department of Hematology, Istituto di Ricovero e Cura a Carattere Scientifico Istituto Tumori Giovanni Paolo II, Bari, Italy.
[22]
Unit of Hematology, Dipartimento di Medicina Specialistica, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
[23]
Division of Medical Oncology and Immune-Related Tumors, Centro di Riferimento Oncologico Istituto di Ricovero e Cura a Carattere Scientifico, Aviano, Italy.
[24]
Department of Oncology, Oslo University Hospital, Oslo, Norway.;K.G. Jebsen Center for B-Cell Malignancies, University of Oslo, Oslo, Norway.
[25]
Department of Internal Medicine, Hematology and Oncology, Brno University Hospital, Brno, Czech Republic.
[26]
Department of Haematology, University College London Hospitals NHS Trust, London, United Kingdom.
[27]
Clinical Oncology Department, Guy's Cancer Center, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
[28]
Department of Oncology, Skane University Hospital, Lund University, Lund, Sweden.
[29]
Clinic of Hematology, Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.;Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland.
[30]
Southampton Clinical Trials Unit, University of Southampton, Southampton, United Kingdom.
[31]
Institute of Oncology Research, Bellinzona, Switzerland.
[32]
Fondazione Italiana Linfomi Onlus, Alessandria, Italy.
[33]
Department of Medical Oncology, Charles University, General Hospital, Prague, Czech Republic.
[34]
Department of Oncology, University of Turin, Turin, Italy.
[35]
Clinical Trials Unit, School of Cancer Sciences, University of Southampton, Southampton, United Kingdom.
[36]
医学主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);女(雌)性(Female);人类(Humans);男(雄)性(Male);中年人(Middle Aged);青年人(Young Adult);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);环磷酰胺(Cyclophosphamide);多柔比星(Doxorubicin);免疫疗法(Immunotherapy);淋巴瘤, B细胞(Lymphoma, B-Cell);纵隔肿瘤(Mediastinal Neoplasms);泼尼松(Prednisone);治疗结果(Treatment Outcome);长春新碱(Vincristine)
DOI
10.1182/blood.2025028823
PMID
40939190
发布时间
2026-01-05
- 浏览0
Blood
Blood
2758-2764页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
